The clinical management of chronic coronary syndrome requires precise risk stratification by means of symptom analysis, imaging and invasive diagnostics. An important aspect is the assessment of ischemia in non-obstructive coronary arteries (INOCA), which includes functional testing of the microcirculation in the cardiac catheterization laboratory. In the context of acute coronary syndrome, including myocardial infarction, the distinction between STEMI and NSTEMI determines the need for immediate coronary angiography. For patients with multivessel disease in STEMI, complete revascularization is recommended based on current studies.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Cardiogenic shock - 2025 update
Between standardization, team processes and targeted cycle support
- Collagenoses
Scleroderma – Current recommendations for diagnosis and therapy 2025
- Multiple sclerosis
Avoiding the nocebo trap with natalizumab biosimilars
- COPD and comorbidities
Exacerbation frequency is associated with cardiopulmonary disease burden
- Multiple myeloma
DREAMM-8: Key study in the development of BCMA therapy up to DREAMM-14
- Catheter ablation for atrial fibrillation 2025
Pulsed field versus radio frequency – where do we stand?
- Atopic dermatitis
From skin barrier disorder to atopic march?
- From the late residual valve to independent therapy